• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用聚(磷腈)-聚(环氧乙烷)共聚物进行表面修饰的长循环可生物降解聚(磷腈)纳米颗粒。

Long circulating biodegradable poly(phosphazene) nanoparticles surface modified with poly(phosphazene)-poly(ethylene oxide) copolymer.

作者信息

Vandorpe J, Schacht E, Dunn S, Hawley A, Stolnik S, Davis S S, Garnett M C, Davies M C, Illum L

机构信息

Department of Organic Chemistry, Biomaterials and Polymer Research Group, University of Ghent, Belgium.

出版信息

Biomaterials. 1997 Sep;18(17):1147-52. doi: 10.1016/s0142-9612(97)00052-5.

DOI:10.1016/s0142-9612(97)00052-5
PMID:9259511
Abstract

The biodistribution of biodegradable poly(organo phosphazene) nanoparticles surface modified by adsorption of a novel poly(organo phosphazene)-poly(ethylene oxide) copolymer with a 5000 M(W) PEO chain (PF-PEO[5000]), following intravenous administration in rats and rabbits, is described. The data are compared to the biodistribution of poly(organo phosphazene) and poly(lactide-co-glycolide) nanoparticles coated with a tetrafunctional copolymer of poly(ethylene oxide)-poly(propylene oxide) ethylenediamine, commercially available as Poloxamine 908. This copolymer has a PEO chain of the same size as the poly(organo phosphazene)-PEO derivative used. The results in the rat model reveal that poly(organo phosphazene) nanoparticles with a Poloxamine 908 coating were mainly captured by the liver, although a retardation in clearance from the systemic circulation was seen. In contrast, the poly(organo phosphazene) nanoparticles coated with PF-PEO(5000) showed a prolonged blood circulating profile, with only a small amount of the nanoparticles sequestered by the liver. This indicates the importance of the nature of both the anchoring group and the particle surface on the biological performances of the system. Study of the biodistribution of the PF-PEO(5000)-coated poly(organo phosphazene) nanoparticles in the rabbit model also indicated a prolonged systemic circulation lifetime and reduced liver uptake, whereby a significant amount of the administered nanoparticles was targeted to the bone marrow.

摘要

描述了一种新型聚(有机磷腈)-聚(环氧乙烷)共聚物(PEO链分子量为5000,PF-PEO[5000])吸附修饰的可生物降解聚(有机磷腈)纳米颗粒在大鼠和兔子静脉注射后的生物分布情况。将这些数据与涂覆有聚(环氧乙烷)-聚(环氧丙烷)乙二胺四官能共聚物(商品名为泊洛沙明908)的聚(有机磷腈)和聚(丙交酯-乙交酯)纳米颗粒的生物分布进行了比较。该共聚物的PEO链大小与所使用的聚(有机磷腈)-PEO衍生物相同。大鼠模型的结果表明,涂覆有泊洛沙明908的聚(有机磷腈)纳米颗粒主要被肝脏捕获,尽管从体循环中的清除有所延迟。相比之下,涂覆有PF-PEO(5000)的聚(有机磷腈)纳米颗粒显示出延长的血液循环曲线,只有少量纳米颗粒被肝脏截留。这表明锚定基团和颗粒表面的性质对该系统生物学性能的重要性。对涂覆有PF-PEO(5000)的聚(有机磷腈)纳米颗粒在兔子模型中的生物分布研究也表明其体循环寿命延长且肝脏摄取减少,从而大量给药的纳米颗粒靶向至骨髓。

相似文献

1
Long circulating biodegradable poly(phosphazene) nanoparticles surface modified with poly(phosphazene)-poly(ethylene oxide) copolymer.用聚(磷腈)-聚(环氧乙烷)共聚物进行表面修饰的长循环可生物降解聚(磷腈)纳米颗粒。
Biomaterials. 1997 Sep;18(17):1147-52. doi: 10.1016/s0142-9612(97)00052-5.
2
Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation.泊洛沙姆407和泊洛沙胺908表面修饰的聚(丙交酯-共-乙交酯)纳米颗粒中的药物递送:体外表征与体内评价
J Control Release. 2001 Feb 23;70(3):353-63. doi: 10.1016/s0168-3659(00)00367-9.
3
Erythropoietin loaded microspheres prepared from biodegradable LPLG-PEO-LPLG triblock copolymers: protein stabilization and in-vitro release properties.由可生物降解的LPLG-PEO-LPLG三嵌段共聚物制备的载促红细胞生成素微球:蛋白质稳定性及体外释放特性
J Control Release. 1998 Dec 4;56(1-3):105-15. doi: 10.1016/s0168-3659(98)00070-4.
4
PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats.聚乙二醇化聚乳酸-羟基乙酸共聚物纳米粒作为蛋白质载体:大鼠体内的合成、制备及生物分布
J Control Release. 2001 Apr 2;71(2):203-11. doi: 10.1016/s0168-3659(01)00218-8.
5
Novel polyphosphazene/poly(lactide-co-glycolide) blends: miscibility and degradation studies.新型聚磷腈/聚(丙交酯-共-乙交酯)共混物:混溶性与降解研究
Biomaterials. 1997 Dec;18(23):1565-9. doi: 10.1016/s0142-9612(97)80009-9.
6
Integration of surface modification and 3D fabrication techniques to prepare patterned poly(L-lactide) substrates allowing regionally selective cell adhesion.整合表面改性和3D制造技术以制备允许区域选择性细胞粘附的图案化聚(L-丙交酯)底物。
J Biomater Sci Polym Ed. 1998;9(2):89-110. doi: 10.1163/156856298x00451.
7
Biodegradable polymeric nanospheres formed by temperature-induced phase transition in a mixture of poly(lactide-co-glycolide) and poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) triblock copolymer.由聚(丙交酯-乙交酯)和聚(环氧乙烷)-聚(环氧丙烷)-聚(环氧乙烷)三嵌段共聚物混合物中的温度诱导相转变形成的可生物降解聚合物纳米球。
Biomacromolecules. 2002 Sep-Oct;3(5):1115-9. doi: 10.1021/bm020066h.
8
Biodegradable polymeric microparticles for drug delivery and vaccine formulation: the surface attachment of hydrophilic species using the concept of poly(ethylene glycol) anchoring segments.用于药物递送和疫苗制剂的可生物降解聚合物微粒:利用聚乙二醇锚定链段概念进行亲水性物质的表面连接。
Biomaterials. 1997 Sep;18(17):1153-61. doi: 10.1016/s0142-9612(97)00051-3.
9
Preparation of DHAQ-loaded mPEG-PLGA-mPEG nanoparticles and evaluation of drug release behaviors in vitro/in vivo.载二氢青蒿素的甲氧基聚乙二醇-聚乳酸-羟基乙酸共聚物-甲氧基聚乙二醇纳米粒的制备及其体外/体内药物释放行为评价
J Mater Sci Mater Med. 2006 Jun;17(6):509-16. doi: 10.1007/s10856-006-8933-3.
10
Surface modification of poly(lactide-co-glycolide) nanospheres by biodegradable poly(lactide)-poly(ethylene glycol) copolymers.可生物降解的聚乳酸-聚乙二醇共聚物对聚(丙交酯-乙交酯)纳米球的表面改性
Pharm Res. 1994 Dec;11(12):1800-8. doi: 10.1023/a:1018931820564.

引用本文的文献

1
Polymeric Lipid Hybrid Nanoparticles (PLNs) as Emerging Drug Delivery Platform-A Comprehensive Review of Their Properties, Preparation Methods, and Therapeutic Applications.聚合物脂质杂化纳米颗粒(PLNs)作为新兴的药物递送平台——对其性质、制备方法和治疗应用的全面综述
Pharmaceutics. 2021 Aug 18;13(8):1291. doi: 10.3390/pharmaceutics13081291.
2
Inhibition of bone loss with surface-modulated, drug-loaded nanoparticles in an intraosseous model of prostate cancer.在前列腺癌骨内模型中,用表面调制的载药纳米颗粒抑制骨质流失。
J Control Release. 2016 Jun 28;232:83-92. doi: 10.1016/j.jconrel.2016.04.019. Epub 2016 Apr 15.
3
Stealth properties to improve therapeutic efficacy of drug nanocarriers.
改善药物纳米载体治疗效果的隐身特性。
J Drug Deliv. 2013;2013:374252. doi: 10.1155/2013/374252. Epub 2013 Mar 7.
4
Design opportunities for actively targeted nanoparticle vaccines.主动靶向纳米颗粒疫苗的设计机遇。
Nanomedicine (Lond). 2008 Jun;3(3):343-55. doi: 10.2217/17435889.3.3.343.
5
An assessment of the effects of shell cross-linked nanoparticle size, core composition, and surface PEGylation on in vivo biodistribution.壳交联纳米颗粒大小、核组成及表面聚乙二醇化对体内生物分布影响的评估。
Biomacromolecules. 2005 Sep-Oct;6(5):2541-54. doi: 10.1021/bm050260e.
6
Chitosan-gadopentetic acid complex nanoparticles for gadolinium neutron-capture therapy of cancer: preparation by novel emulsion-droplet coalescence technique and characterization.用于癌症钆中子俘获治疗的壳聚糖-钆喷替酸复合物纳米颗粒:通过新型乳液滴聚并技术制备及表征
Pharm Res. 1999 Dec;16(12):1830-5. doi: 10.1023/a:1018995124527.
7
Modification of the copolymers poloxamer 407 and poloxamine 908 can affect the physical and biological properties of surface modified nanospheres.共聚物泊洛沙姆407和泊洛沙明908的改性会影响表面改性纳米球的物理和生物学性质。
Pharm Res. 1998 Feb;15(2):318-24. doi: 10.1023/a:1011987206722.